In a specific in vivo study targeting Parkinson’s disease (PD) treatment, researchers explored the potential benefits of using bFGF (basic fibroblast growth factor) on rats after performing a complete decellularization protocol and analyzing the tissue through hematoxylin and eosin and DAPI staining. The gene discussed is FGF2; the disease is Parkinson disease.